Patent ID: 7435756

Claim:
A method of treatment for Type II diabetes and its complications and associated conditions comprising administering a compound selected from formula (1) (Gibberellins) wherein R 1 is H or a group —O—R 20 , where R 20 is H, or R 1 together with R 2 forms a bond (C 1 -C 2 double bond); R 2 is H or a group —O—R 21 , where R 21 is H, or R 2 together with R 1 or R 3 forms a bond (C 1 -C 2 or C 2 -C 3 double bond, respectively); R 3 is H, ═O, or —O—R 22 , where R 22 is H, or R 3 together with R 2 forms a bond (C 2 -C 3 double bond); R 4 together with R 28 forms a bond (lactone); R 5 is H , or unsubstituted or substituted C 1˜20 alkyl esters, allyl esters, active esters; R 6 is H or OH or together with R 7 forms a bond (C 11 -C 12 double bond); R 7 is H or —OR 26 , where R 26 is H or R 7 together with R 6 forms a bond (C 11 -C 12 double bond); R 8 is H or hydroxyl; R 9 is H or OH; R 10 —OR 28 , where R 28 together with R 4 forms a bond (lactone); R 11 is absent; R 12 is CH 3 ; R 13 is methylene; R 14 is H; R 15 is H; and its pharmaceutically acceptable lactones, esters, active esters, salts and organic bases, in combination with other compatible therapeutic agents selected from the group consisting of analgesics, anti-hypertensive agents, sedatives, hypnotics, lipid-lowering agents, and anti-infective agents or combinations thereof, to a patient in need thereof.